Silver

Silver

SCHEMBL4964258

O=C([O-])c1ccccc1C(F)(F)F.[Ag+]

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

folP

The experimentally established mechanism targets of Silver. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.58
▸ GAA P10253 1/20 0.58
▸ CNR2 P34972 2/20 0.47
▸ KCNK3 O14649 1/20 0.47
▸ KCNK9 Q9NPC2 1/20 0.47
▸ CTNNB1 P35222 4/20 0.47
▸ WNT3A P56704 4/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ PTGS1 P23219 1/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ SLC6A2 P23975 1/20 0.43
▸ SLC6A4 P31645 1/20 0.43
▸ NFKB1 P19838 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Zinc Ion SCHEMBL9460998 0.96 LMNA (0.58) LMNAGAACNR2KCNK3KCNK9
Lithium Ion SCHEMBL29208532 0.96 LMNA (0.58) LMNAGAACNR2KCNK3KCNK9
SCHEMBL25404889 0.96 LMNA (0.58) LMNAGAACNR2KCNK3KCNK9
SCHEMBL4961644 0.86 LMNA (0.49) LMNAGAACNR2KCNK3KCNK9
SCHEMBL28634751 0.80 LMNA (0.64) LMNAGAACNR2KCNK3KCNK9
SCHEMBL746794 0.80 LMNA (0.64) LMNAGAACNR2KCNK3KCNK9
Tetrabuthylammonium SCHEMBL23522678 0.79 LMNA (0.43) LMNAGAACNR2CTNNB1WNT3A
SCHEMBL19516460 0.79 LMNA (0.44) LMNAGAACNR2KCNK3KCNK9
SCHEMBL27142668 0.79 LMNA (0.44) LMNAGAACNR2KCNK3KCNK9
SCHEMBL5794560 0.78 LMNA (0.62) LMNAGAACNR2KCNK3KCNK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1314725-B1 SULFONIUM SALT COMPOUND WAKO PURE CHEM IND LTD (JP) 2008-03-19 — — EP disclosed
US-6924323-B2 Sulfonium salt compound WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2005-08-02 — — US disclosed
US-20040033434-A1 Sulfonium salt compound FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2004-02-19 — — US disclosed
EP-1314725-A1 SULFONIUM SALT COMPOUND Wako Pure Chemical Industries, Ltd. (JP) 2003-05-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040033434-A1 Sulfonium salt compound SPIN1, RER1, SPIN2B LMNA 4486/4885GAA 4471/4885CNR2 1641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback